Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neoplasms 1Multi-centric Castleman's Disease 1Macular dystrophy, corneal type 1 1Lymphoproliferative Disorders 1Lymphadenopathy 1HIV Infections 1

Interventions

Cyclophosphamide 5Rituximab 4Vincristine 3Prednisone 3Doxorubicin 3Etoposide 2venetoclax 1pembrolizumab 1liposomal doxorubicin 1ibrutinib 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1acalabrutinib 1Zidovudine 1Whole-Body Irradiation 1Valganciclovir 1Tacrolimus 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Nivolumab 1Mycophenolic Acid 1Mesna 1Melphalan 1Interferon-alpha 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1CLR1404 1CA-4948 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoproliferative Disorders × Zidovudine × 90 days × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡